Published On : 2019-06-18
Beckman Coulter Life Sciences, a US-based Danaher company focusing on healthcare through discovery and research, has acquired Cytobank, an American cloud-based informatics platform for single cell analysis, according to its recent press release. Cytobank’s technology naturally complements the CytoFLEX LX Flow Cytometer of Beckman Coulter Life Sciences. This combination is meant to help meet the increasing high-complexity data and workflow analysis requirements of clinical as well as basic research scientists. Under the Danaher Life Sciences platform, Cytobank will transition into Beckman Coulter Life Sciences, as part of the acquisition deal. Danaher’s Life Sciences segment earned around $6.5 billion last year.
“Our company is looking forward to join Beckman Coulter Life Sciences, and leverage synergies for helping us further support and develop Cytobank’s platform to globally serve leading scientists,” said President of Cytobank, David Craford.
Acquisition to help Beckman Coulter Life Sciences provide flexible high-end data analytics solutions
Cytobank’s industry-best machine learning and cloud-based software platform is used for multi-parametric single-cell data archiving, sharing, and analysis. It speeds up research productivity by allowing competent high-dimensional multi-omics data collaboration, visualization, and analysis across several sites. Cytobank’s SaaS solution helps to deeply understand complex biology at the single cell level. It is used by academic, biotechnology, and pharma researchers around the world.
“Beckman Coulter Life Sciences is excited to add customer workflow-focused team and innovative software solutions of Cytobank to its flow cytometry business. For leading academic and pharma/biopharma clinical research customers, our company can now offer high-end data analytics solutions that are more standardized yet flexible,” said Beckman Coulter Life Sciences’ Vice President and General Manager for Flow Cytometry Business Unit, Mario Koksch.
Beckman Coulter Life Sciences is a division of Beckman Coulter, a US manufacturer of products that innovate, automate, and simplify complex biomedical testing. Beckman Coulter has served laboratory professionals for over 80 years and is dedicated to optimizing and advancing laboratories. One of its important goals is helping laboratory professionals to advance patient care and scientific research. According to the company, it has become a choice partner for industrial, research, and clinical customers across the world because of its focus on efficiency, reliability, and innovation.
Request for data as per your requirement
Get specifications suitable to your business
Receive an in-depth and unique understanding of the subject matter
Acquire insight into specific area of the industry